Residential Rehab

CIWA-Ar is a 10-item clinician-administered scale used to rate the severity of alcohol withdrawal symptoms and help guide monitoring and treatment decisions.

Rehab programs may use drug testing to identify recent substance exposure, monitor treatment progress, support medication safety, and guide clinical decisions; testing should be interpreted in context rather than used punitively.

Lab testing at rehab admission varies by clinical need and setting, but may include toxicology testing and selected blood, urine, pregnancy, or infectious-disease tests when medically indicated.

A positive drug test at rehab admission is generally one piece of clinical information used to assess recent substance exposure, withdrawal risk, safety, and treatment needs; it should not be interpreted in isolation.

If you arrive at rehab intoxicated, staff should first assess safety, intoxication severity, withdrawal risk, medical needs, and the appropriate level of care before routine treatment begins.

A rehab may share records with another treatment program when HIPAA and 42 CFR Part 2 requirements are satisfied, including appropriate patient consent when required.

How long addiction treatment records are kept depends on state law, program type, payer requirements, and organizational policy; HIPAA itself does not set a medical-record retention period.

Patients generally have a right under HIPAA to access copies of health information in a designated record set after discharge, subject to limited exceptions and any additional protections that apply to substance use disorder records.

A rehab discharge summary typically documents the reason for treatment, diagnoses, services provided, progress, medications, discharge status, continuing-care plan, and follow-up recommendations.

PTO and FMLA can often run at the same time when the leave qualifies under FMLA and the employer’s paid-leave policy allows or requires substitution of paid leave.